Select Medical Holdings CorporationSEMNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -110.06% | -24.35% | +4.51% | -22.59% | +0.00% |
| Gross Profit Growth | -246.91% | -38.63% | -2.73% | -37.87% | +0.00% |
| EBITDA Growth | -265.12% | -38.07% | -2.02% | -43.63% | +0.00% |
| Operating Income Growth | -448.31% | -41.87% | +17.16% | -48.31% | +0.00% |
| Net Income Growth | -134.69% | -41.50% | -47.69% | -48.24% | +0.00% |
| EPS Growth | -133.33% | -41.33% | -46.67% | -46.51% | +0.00% |
| EPS Diluted Growth | -133.33% | -41.33% | -46.67% | -46.51% | +0.00% |
| Weighted Average Shares Growth | +4.33% | +3.99% | -0.47% | -0.97% | -4.40% |
| Weighted Average Shares Diluted Growth | +4.33% | +1.89% | -0.47% | -0.97% | -4.40% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -30.10% | +0.00% | -60.35% | -3.13% | -48.72% |
| Free Cash Flow Growth | -47.83% | +0.00% | -79.51% | -6.20% | -91.57% |
| Receivables Growth | +13.43% | -19.97% | -15.63% | -22.09% | +5.21% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -27.07% | -27.52% | -27.09% | -28.95% | +4.34% |
| Book Value per Share Growth | +25.09% | +20.92% | +18.24% | -10.93% | +6.10% |
| Debt Growth | -40.23% | -45.46% | -42.50% | -77.42% | +36.97% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +81.89% | -31.87% | -28.50% | -15.41% | -43.02% |